Related Experiment Video
Updated: Apr 7, 2026
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Direct Cardiac Reprogramming: Advances in Cardiac Regeneration
1Department of Pathology and Laboratory Medicine, McAllister Heart Institute, University of North Carolina, Chapel Hill, NC 27599, USA.
Insights
Direct cardiac reprogramming converts fibroblasts into cardiomyocyte-like cells, offering a promising new approach for heart repair after injury. This regenerative medicine strategy aims to restore heart function by generating new heart cells in situ.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Cellular Reprogramming
Background:
- Heart disease causes widespread mortality, often leading to irreversible cardiomyocyte death and heart failure.
- Current treatments for cardiac injury have limited efficacy due to the heart's poor regenerative capacity.
- Fibroblast activation and scar formation after injury do not restore cardiac function.
Purpose of the Study:
- To review the history, progress, methods, challenges, and future directions of direct cardiac reprogramming.
- To explore the potential of converting fibroblasts into cardiomyocytes for cardiac repair.
- To highlight advancements in in vitro and in vivo direct reprogramming techniques.
Main Methods:
- Direct reprogramming of fibroblasts into cardiomyocyte-like cells.
- In vitro and in vivo experimental models.
- Assessment of functional improvements in myocardial infarction models.
Main Results:
- Successful generation of cardiomyocyte-like cells from endogenous fibroblasts in mouse models.
- Demonstrated functional improvements in mouse models of myocardial infarction.
- Early-stage but promising results for in situ cardiac regeneration.
Conclusions:
- Direct cardiac reprogramming is a nascent technology with significant potential for regenerative medicine.
- This approach offers a novel strategy to restore cardiac function by generating new cardiomyocytes.
- Further research is needed to overcome challenges and translate this technology into clinical applications.
Abstract:
Heart disease is one of the lead causes of death worldwide. Many forms of heart disease, including myocardial infarction and pressure-loading cardiomyopathies, result in irreversible cardiomyocyte death. Activated fibroblasts respond to cardiac injury by forming scar tissue, but ultimately this response fails to restore cardiac function. Unfortunately, the human heart has little regenerative ability and long-term outcomes following acute coronary events often include chronic and end-stage heart failure. Building upon years of research aimed at restoring functional cardiomyocytes, recent advances have been made in the direct reprogramming of fibroblasts toward a cardiomyocyte cell fate both in vitro and in vivo. Several experiments show functional improvements in mouse models of myocardial infarction following in situ generation of cardiomyocyte-like cells from endogenous fibroblasts. Though many of these studies are in an early stage, this nascent technology holds promise for future applications in regenerative medicine. In this review, we discuss the history, progress, methods, challenges, and future directions of direct cardiac reprogramming.
